APO Research, Inc.

APO RESEARCH · REPORT

Melatonin

Melatonin, also known as N-acetyl-5-methoxy tryptamine, is a hormone that is produced by the pineal gland in animals and regulates sleep and wakefulness. Melatonin is also produced in plants where it functions as a first line of defense against oxidative stress.

Product & engineering

Understand the product.

Melatonin, also known as N-acetyl-5-methoxy tryptamine, is a hormone that is produced by the pineal gland in animals and regulates sleep and wakefulness. Melatonin is also produced in plants where it functions as a first line of defense against oxidative stress.

Selected research

Market Analysis & Forecast

Global Melatonin Market Analysis and Forecast 2026-2032

Market perspective

Melatonin, also known as N-acetyl-5-methoxy tryptamine, is a hormone that is produced by the pineal gland in animals and regulates sleep and wakefulness. Melatonin is also produced in plants where it functions as a first line of defense against oxidative stress.

Neurim Pharma, Natrol, Pharmavite, Nature's Bounty and Jameison are the leaders of the Melatonin industry, which take about 30% market share. North America and Europe are the major region of the global market, which takes about 70% market share.

Report Includes

Read the full market overview

This report presents an overview of global market for Melatonin, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Melatonin, also provides the revenue of main regions and countries. Of the upcoming market potential for Melatonin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Melatonin revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Melatonin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Melatonin revenue, projected growth trends, production technology, application and end-user industry.

Melatonin Segment by Company

Natrol

Pharmavite

Nature's Bounty

Jameison

Rexall Sundown

GNC

Xiu Zheng

Church & Dwight

By-Health

Pfizer

Solgar

Biotics Research

Now Food

Melatonin Segment by Type

Pharmaceutical Grade Melatonin

Food Grade Melatonin

Melatonin Segment by Application

Dietary Supplements

Medical

Others

Melatonin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Melatonin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Melatonin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Melatonin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Melatonin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Melatonin company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Melatonin revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Melatonin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pharmaceutical Grade Melatonin Major Player Table 3. Food Grade Melatonin Major Player Table 4. Global Melatonin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Dietary Supplements Major Player Table 6. Medical Major Player Table 7. Others Major Player Table 8. Melatonin Industry Trends Table 9. Melatonin Industry Drivers Table 10. Melatonin Industry Opportunities and Challenges Table 11. Melatonin Industry Restraints Table 12. Global Melatonin Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Melatonin Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Melatonin Market Share by Region (2021-2026) Table 15. Global Melatonin Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Melatonin Market Share by Region (2027-2032) Table 17. Global Melatonin Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Melatonin Revenue Market Share by Players (2021-2026) Table 19. Global Melatonin Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Melatonin Key Players Headquarters & Area Served Table 21. Global Melatonin Players, Product Type & Application Table 22. Global Melatonin Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Melatonin by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Melatonin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Melatonin Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Melatonin Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Melatonin Revenue Market Share by Type (2021-2026) Table 29. Global Melatonin Revenue Market Share by Type (2027-2032) Table 30. Global Melatonin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Melatonin Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Melatonin Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Melatonin Revenue Market Share by Application (2021-2026) Table 34. Global Melatonin Revenue Market Share by Application (2027-2032) Table 35. Natrol Company Information Table 36. Natrol Business Overview Table 37. Natrol Melatonin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Natrol Melatonin Product Portfolio Table 39. Natrol Recent Development Table 40. Pharmavite Company Information Table 41. Pharmavite Business Overview Table 42. Pharmavite Melatonin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Pharmavite Melatonin Product Portfolio Table 44. Pharmavite Recent Development Table 45. Nature's Bounty Company Information Table 46. Nature's Bounty Business Overview Table 47. Nature's Bounty Melatonin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Nature's Bounty Melatonin Product Portfolio Table 49. Nature's Bounty Recent Development Table 50. Jameison Company Information Table 51. Jameison Business Overview Table 52. Jameison Melatonin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Jameison Melatonin Product Portfolio Table 54. Jameison Recent Development Table 55. Rexall Sundown Company Information Table 56. Rexall Sundown Business Overview Table 57. Rexall Sundown Melatonin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Rexall Sundown Melatonin Product Portfolio Table 59. Rexall Sundown Recent Development Table 60. GNC Company Information Table 61. GNC Business Overview Table 62. GNC Melatonin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. GNC Melatonin Product Portfolio Table 64. GNC Recent Development Table 65. Xiu Zheng Company Information Table 66. Xiu Zheng Business Overview Table 67. Xiu Zheng Melatonin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Xiu Zheng Melatonin Product Portfolio Table 69. Xiu Zheng Recent Development Table 70. Church & Dwight Company Information Table 71. Church & Dwight Business Overview Table 72. Church & Dwight Melatonin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Church & Dwight Melatonin Product Portfolio Table 74. Church & Dwight Recent Development Table 75. By-Health Company Information Table 76. By-Health Business Overview Table 77. By-Health Melatonin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. By-Health Melatonin Product Portfolio Table 79. By-Health Recent Development Table 80. Pfizer Company Information Table 81. Pfizer Business Overview Table 82. Pfizer Melatonin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Pfizer Melatonin Product Portfolio Table 84. Pfizer Recent Development Table 85. Solgar Company Information Table 86. Solgar Business Overview Table 87. Solgar Melatonin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. Solgar Melatonin Product Portfolio Table 89. Solgar Recent Development Table 90. Biotics Research Company Information Table 91. Biotics Research Business Overview Table 92. Biotics Research Melatonin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Biotics Research Melatonin Product Portfolio Table 94. Biotics Research Recent Development Table 95. Now Food Company Information Table 96. Now Food Business Overview Table 97. Now Food Melatonin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Now Food Melatonin Product Portfolio Table 99. Now Food Recent Development Table 100. North America Melatonin Revenue by Type (2021-2026) & (US$ Million) Table 101. North America Melatonin Revenue by Type (2027-2032) & (US$ Million) Table 102. North America Melatonin Revenue by Application (2021-2026) & (US$ Million) Table 103. North America Melatonin Revenue by Application (2027-2032) & (US$ Million) Table 104. North America Melatonin Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Melatonin Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Melatonin Revenue by Country (US$ Million) & (2027-2032) Table 107. Europe Melatonin Revenue by Type (2021-2026) & (US$ Million) Table 108. Europe Melatonin Revenue by Type (2027-2032) & (US$ Million) Table 109. Europe Melatonin Revenue by Application (2021-2026) & (US$ Million) Table 110. Europe Melatonin Revenue by Application (2027-2032) & (US$ Million) Table 111. Europe Melatonin Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Melatonin Revenue by Country (2021-2026) & (US$ Million) Table 113. Europe Melatonin Revenue by Country (US$ Million) & (2027-2032) Table 114. China Melatonin Revenue by Type (2021-2026) & (US$ Million) Table 115. China Melatonin Revenue by Type (2027-2032) & (US$ Million) Table 116. China Melatonin Revenue by Application (2021-2026) & (US$ Million) Table 117. China Melatonin Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Melatonin Revenue by Type (2021-2026) & (US$ Million) Table 119. Asia Melatonin Revenue by Type (2027-2032) & (US$ Million) Table 120. Asia Melatonin Revenue by Application (2021-2026) & (US$ Million) Table 121. Asia Melatonin Revenue by Application (2027-2032) & (US$ Million) Table 122. Asia Melatonin Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Asia Melatonin Revenue by Region (US$ Million) & (2021-2026) Table 124. Asia Melatonin Revenue by Region (US$ Million) & (2027-2032) Table 125. SAMEA Melatonin Revenue by Type (2021-2026) & (US$ Million) Table 126. SAMEA Melatonin Revenue by Type (2027-2032) & (US$ Million) Table 127. SAMEA Melatonin Revenue by Application (2021-2026) & (US$ Million) Table 128. SAMEA Melatonin Revenue by Application (2027-2032) & (US$ Million) Table 129. SAMEA Melatonin Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. SAMEA Melatonin Revenue by Country (2021-2026) & (US$ Million) Table 131. SAMEA Melatonin Revenue by Country (US$ Million) & (2027-2032) Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Melatonin Image Figure 2. Global Melatonin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Melatonin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pharmaceutical Grade Melatonin Image Figure 5. Food Grade Melatonin Image Figure 6. Global Melatonin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Melatonin Market Size Share 2021 VS 2025 VS 2032 Figure 8. Dietary Supplements Image Figure 9. Medical Image Figure 10. Others Image Figure 11. Global Melatonin Market Size (US$ Million) & (2021-2032) Figure 12. Global Melatonin Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Melatonin Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Melatonin Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Melatonin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Melatonin Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Melatonin Revenue Market Share by Type (2021-2032) Figure 19. Global Melatonin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Melatonin Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Melatonin Revenue Market Share by Application (2021-2032) Figure 22. North America Melatonin Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Melatonin Revenue Share by Type (2021-2032) Figure 24. North America Melatonin Revenue Share by Application (2021-2032) Figure 25. North America Melatonin Revenue Share by Country (2021-2032) Figure 26. United States Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Melatonin Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Melatonin Revenue Share by Type (2021-2032) Figure 31. Europe Melatonin Revenue Share by Application (2021-2032) Figure 32. Europe Melatonin Revenue Share by Country (2021-2032) Figure 33. Germany Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Melatonin Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Melatonin Revenue Share by Type (2021-2032) Figure 43. China Melatonin Revenue Share by Application (2021-2032) Figure 44. Asia Melatonin Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Melatonin Revenue Share by Type (2021-2032) Figure 46. Asia Melatonin Revenue Share by Application (2021-2032) Figure 47. Asia Melatonin Revenue Share by Region (2021-2032) Figure 48. Japan Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Melatonin Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Melatonin Revenue Share by Type (2021-2032) Figure 56. SAMEA Melatonin Revenue Share by Application (2021-2032) Figure 57. SAMEA Melatonin Revenue Share by Country (2021-2032) Figure 58. Brazil Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Melatonin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceutical Grade Melatonin
  • Food Grade Melatonin
Applications
  • Dietary Supplements
  • Medical
  • Others
Companies covered
  • Natrol
  • Pharmavite
  • Nature's Bounty
  • Jameison
  • Rexall Sundown
  • GNC
  • Xiu Zheng
  • Church & Dwight
  • By-Health
  • Pfizer
  • Solgar
  • Biotics Research
  • Now Food

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Melatonin Market by Type
  3. 1.2.1 Global Melatonin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pharmaceutical Grade Melatonin
  5. 1.2.3 Food Grade Melatonin
  6. 1.3 Melatonin Market by Application
  7. 1.3.1 Global Melatonin Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Dietary Supplements
  9. 1.3.3 Medical
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Melatonin Market Dynamics
  1. 2.1 Melatonin Industry Trends
  2. 2.2 Melatonin Industry Drivers
  3. 2.3 Melatonin Industry Opportunities and Challenges
  4. 2.4 Melatonin Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Melatonin Market Perspective (2021-2032)
  2. 3.2 Global Melatonin Growth Trends by Region
  3. 3.2.1 Global Melatonin Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Melatonin Market Size by Region (2021-2026)
  5. 3.2.3 Global Melatonin Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Melatonin Revenue by Players
  2. 4.1.1 Global Melatonin Revenue by Players (2021-2026)
  3. 4.1.2 Global Melatonin Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Melatonin Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Melatonin Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Melatonin Key Players Headquarters & Area Served
  7. 4.4 Global Melatonin Players, Product Type & Application
  8. 4.5 Global Melatonin Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Melatonin Market CR5 and HHI
  11. 4.6.3 2025 Melatonin Tier 1, Tier 2, and Tier 3
5 Melatonin Market Size by Type
  1. 5.1 Global Melatonin Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Melatonin Revenue by Type (2021-2032)
  3. 5.3 Global Melatonin Revenue Market Share by Type (2021-2032)
6 Melatonin Market Size by Application
  1. 6.1 Global Melatonin Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Melatonin Revenue by Application (2021-2032)
  3. 6.3 Global Melatonin Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Natrol
  2. 7.1.1 Natrol Company Information
  3. 7.1.2 Natrol Business Overview
  4. 7.1.3 Natrol Melatonin Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Natrol Melatonin Product Portfolio
  6. 7.1.5 Natrol Recent Developments
  7. 7.2 Pharmavite
  8. 7.2.1 Pharmavite Company Information
  9. 7.2.2 Pharmavite Business Overview
  10. 7.2.3 Pharmavite Melatonin Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Pharmavite Melatonin Product Portfolio
  12. 7.2.5 Pharmavite Recent Developments
  13. 7.3 Nature's Bounty
  14. 7.3.1 Nature's Bounty Company Information
  15. 7.3.2 Nature's Bounty Business Overview
  16. 7.3.3 Nature's Bounty Melatonin Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Nature's Bounty Melatonin Product Portfolio
  18. 7.3.5 Nature's Bounty Recent Developments
  19. 7.4 Jameison
  20. 7.4.1 Jameison Company Information
  21. 7.4.2 Jameison Business Overview
  22. 7.4.3 Jameison Melatonin Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Jameison Melatonin Product Portfolio
  24. 7.4.5 Jameison Recent Developments
  25. 7.5 Rexall Sundown
  26. 7.5.1 Rexall Sundown Company Information
  27. 7.5.2 Rexall Sundown Business Overview
  28. 7.5.3 Rexall Sundown Melatonin Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Rexall Sundown Melatonin Product Portfolio
  30. 7.5.5 Rexall Sundown Recent Developments
  31. 7.6 GNC
  32. 7.6.1 GNC Company Information
  33. 7.6.2 GNC Business Overview
  34. 7.6.3 GNC Melatonin Revenue and Gross Margin (2021-2026)
  35. 7.6.4 GNC Melatonin Product Portfolio
  36. 7.6.5 GNC Recent Developments
  37. 7.7 Xiu Zheng
  38. 7.7.1 Xiu Zheng Company Information
  39. 7.7.2 Xiu Zheng Business Overview
  40. 7.7.3 Xiu Zheng Melatonin Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Xiu Zheng Melatonin Product Portfolio
  42. 7.7.5 Xiu Zheng Recent Developments
  43. 7.8 Church & Dwight
  44. 7.8.1 Church & Dwight Company Information
  45. 7.8.2 Church & Dwight Business Overview
  46. 7.8.3 Church & Dwight Melatonin Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Church & Dwight Melatonin Product Portfolio
  48. 7.8.5 Church & Dwight Recent Developments
  49. 7.9 By-Health
  50. 7.9.1 By-Health Company Information
  51. 7.9.2 By-Health Business Overview
  52. 7.9.3 By-Health Melatonin Revenue and Gross Margin (2021-2026)
  53. 7.9.4 By-Health Melatonin Product Portfolio
  54. 7.9.5 By-Health Recent Developments
  55. 7.10 Pfizer
  56. 7.10.1 Pfizer Company Information
  57. 7.10.2 Pfizer Business Overview
  58. 7.10.3 Pfizer Melatonin Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Pfizer Melatonin Product Portfolio
  60. 7.10.5 Pfizer Recent Developments
  61. 7.11 Solgar
  62. 7.11.1 Solgar Company Information
  63. 7.11.2 Solgar Business Overview
  64. 7.11.3 Solgar Melatonin Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Solgar Melatonin Product Portfolio
  66. 7.11.5 Solgar Recent Developments
  67. 7.12 Biotics Research
  68. 7.12.1 Biotics Research Company Information
  69. 7.12.2 Biotics Research Business Overview
  70. 7.12.3 Biotics Research Melatonin Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Biotics Research Melatonin Product Portfolio
  72. 7.12.5 Biotics Research Recent Developments
  73. 7.13 Now Food
  74. 7.13.1 Now Food Company Information
  75. 7.13.2 Now Food Business Overview
  76. 7.13.3 Now Food Melatonin Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Now Food Melatonin Product Portfolio
  78. 7.13.5 Now Food Recent Developments
8 North America
  1. 8.1 North America Melatonin Revenue (2021-2032)
  2. 8.2 North America Melatonin Revenue by Type (2021-2032)
  3. 8.2.1 North America Melatonin Revenue by Type (2021-2026)
  4. 8.2.2 North America Melatonin Revenue by Type (2027-2032)
  5. 8.3 North America Melatonin Revenue Share by Type (2021-2032)
  6. 8.4 North America Melatonin Revenue by Application (2021-2032)
  7. 8.4.1 North America Melatonin Revenue by Application (2021-2026)
  8. 8.4.2 North America Melatonin Revenue by Application (2027-2032)
  9. 8.5 North America Melatonin Revenue Share by Application (2021-2032)
  10. 8.6 North America Melatonin Revenue by Country
  11. 8.6.1 North America Melatonin Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Melatonin Revenue by Country (2021-2026)
  13. 8.6.3 North America Melatonin Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Melatonin Revenue (2021-2032)
  2. 9.2 Europe Melatonin Revenue by Type (2021-2032)
  3. 9.2.1 Europe Melatonin Revenue by Type (2021-2026)
  4. 9.2.2 Europe Melatonin Revenue by Type (2027-2032)
  5. 9.3 Europe Melatonin Revenue Share by Type (2021-2032)
  6. 9.4 Europe Melatonin Revenue by Application (2021-2032)
  7. 9.4.1 Europe Melatonin Revenue by Application (2021-2026)
  8. 9.4.2 Europe Melatonin Revenue by Application (2027-2032)
  9. 9.5 Europe Melatonin Revenue Share by Application (2021-2032)
  10. 9.6 Europe Melatonin Revenue by Country
  11. 9.6.1 Europe Melatonin Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Melatonin Revenue by Country (2021-2026)
  13. 9.6.3 Europe Melatonin Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Melatonin Revenue (2021-2032)
  2. 10.2 China Melatonin Revenue by Type (2021-2032)
  3. 10.2.1 China Melatonin Revenue by Type (2021-2026)
  4. 10.2.2 China Melatonin Revenue by Type (2027-2032)
  5. 10.3 China Melatonin Revenue Share by Type (2021-2032)
  6. 10.4 China Melatonin Revenue by Application (2021-2032)
  7. 10.4.1 China Melatonin Revenue by Application (2021-2026)
  8. 10.4.2 China Melatonin Revenue by Application (2027-2032)
  9. 10.5 China Melatonin Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Melatonin Revenue (2021-2032)
  2. 11.2 Asia Melatonin Revenue by Type (2021-2032)
  3. 11.2.1 Asia Melatonin Revenue by Type (2021-2026)
  4. 11.2.2 Asia Melatonin Revenue by Type (2027-2032)
  5. 11.3 Asia Melatonin Revenue Share by Type (2021-2032)
  6. 11.4 Asia Melatonin Revenue by Application (2021-2032)
  7. 11.4.1 Asia Melatonin Revenue by Application (2021-2026)
  8. 11.4.2 Asia Melatonin Revenue by Application (2027-2032)
  9. 11.5 Asia Melatonin Revenue Share by Application (2021-2032)
  10. 11.6 Asia Melatonin Revenue by Country
  11. 11.6.1 Asia Melatonin Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Melatonin Revenue by Country (2021-2026)
  13. 11.6.3 Asia Melatonin Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Melatonin Revenue (2021-2032)
  2. 12.2 SAMEA Melatonin Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Melatonin Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Melatonin Revenue by Type (2027-2032)
  5. 12.3 SAMEA Melatonin Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Melatonin Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Melatonin Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Melatonin Revenue by Application (2027-2032)
  9. 12.5 SAMEA Melatonin Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Melatonin Revenue by Country
  11. 12.6.1 SAMEA Melatonin Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Melatonin Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Melatonin Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.